Related Experiment Video
Updated: Feb 17, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Evolving treatment paradigms in sickle cell disease.
Ramasamy Jagadeeswaran1,2, Angela Rivers1,2
1Department of Pediatrics, University of Illinois at Chicago, Chicago, IL; and.
Sickle cell disease (SCD) involves red blood cell damage due to hemoglobin S polymerization. Increased reactive oxygen species (ROS) worsen SCD symptoms, and reducing ROS is a key therapeutic target.
Area of Science:
- Hematology
- Molecular Medicine
- Pathophysiology
Background:
- Sickle cell disease (SCD) is an inherited blood disorder.
- It is characterized by abnormal hemoglobin S, leading to red blood cell sickling.
- This causes chronic hemolytic anemia, painful crises, and organ damage.
Purpose of the Study:
- To review the role of reactive oxygen species (ROS) in SCD.
- To discuss emerging therapies targeting ROS reduction in SCD.
Main Methods:
- Literature review of studies on ROS and SCD.
- Analysis of current and developing therapeutic strategies.
Main Results:
- Increased ROS generation is a significant factor in SCD pathophysiology.
- ROS contribute to red blood cell hemolysis and cellular adhesion.
- Therapeutic strategies aimed at reducing ROS show promise for SCD treatment.
Conclusions:
- Reactive oxygen species play a crucial role in the development and progression of sickle cell disease.
- Targeting ROS represents a promising therapeutic avenue for managing SCD and its complications.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Related Concept Videos
Multiple Allele Traits
iPS Cell Differentiation
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Regulation of Hematopoietic Stem Cells
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...